Compliance: Part B Lab Tests Remain a Fixture on the OIG Hit List

Why This Topic Matters

Laboratory services are a major area of Medicare spending and federal oversight. Understanding the compliance environment helps organizations track reimbursement trends, monitor risk areas, and stay aware of federal enforcement priorities affecting clinical diagnostic testing.

Article Sections

1. Background

   Introduces the article’s focus on Medicare lab test payment oversight and the broader compliance environment. It frames the discussion around improper payment monitoring and federal attention to lab-related claims risk.

2. Consider These Recent Stats

   Summarizes recent Medicare payment and improper payment data for laboratory testing. It also places lab spending and fee schedule changes in the context of federal oversight and potential enforcement interest.

3. Bad news

   Discusses concerns that Medicare payment reductions may affect access to testing and laboratory operations. It presents the general compliance and operational implications without detailing specific coding rules.

4. Result

   Describes the addition of a lab-related item to the OIG Work Plan and the continued focus on monitoring Medicare payments. It highlights federal interest in oversight of clinical diagnostic laboratory tests.

5. Warning

   Addresses enforcement concerns involving fraudulent claims and improper financial relationships in the laboratory space. It emphasizes the ongoing role of federal agencies in investigating and penalizing misconduct.

6. Resource

   Lists external references for further background on Medicare laboratory payment policy and related federal reports. It serves as a source list rather than substantive guidance.